Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from SailPoint

Love and hate: tech pros overwhelmingly like AI agents but view them as a growing security risk

Poor oversight, missing policies, and alarming behavior are triggering urgent calls for better identity-based security.

TechRadar

SailPoint Stock Falls On Earnings Report Following IPO

SailPoint stock fell after the cybersecurity firm reported fourth quarter earnings, continuing its slide post initial public offering.

Investors Business Daily

IPO Market Slump Drags On As Unicorns Multiply. Why There's Hope For More IPOs In 2025.

After a downbeat year, investors are eyeing a more robust technology IPO market in 2025. Here's their case for coaxing more unicorns off the sidelines.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

SailPoint Scores Relative Strength Rating Upgrade; Hits Key Benchmark

SailPoint sees its Relative Strength Rating move into the 80-plus level.

Investors Business Daily

SailPoint Return To Public Markets Marks First Major Tech IPO Of 2025

SailPoint stock was trading slightly higher to start the first full day of trading for the cybersecurity company.

Investors Business Daily

How to protect your business in the age of deepfakes

The dangers and risks deepfake technology poses to businesses.

TechRadar

Why Software Stocks Are Looking Tasty To Private Equity Firms

Look for private equity firms to keep on targeting software companies in 2023, though rising interest rates could get in the way of some deals.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Merger Arbitrage Mondays – Bristol Myers (BMY) Acquires Third Point Therapeutics (TPTX)

Another week and another deal with big pharma buying out a development stage oncology company. Given the real synergies to be had through young companies partnering with big pharma to leverage their manufacturing expertise and distribution networks, regulators have allowed most of them to go through and they tend to…

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Wall Street Journal

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.